Anti-inflammatory, analgesic and anti-tumor properties of gold nanoparticles

Gold nanoparticles (GNPs) are regarded as potential platforms for drug delivery. However, their interaction with live organisms must be understood prior to their utilization as drug carriers. The present study reports the anti-inflammatory, analgesic and anti-tumor effects of GNPs. The biodistributi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacological reports 2017-02, Vol.69 (1), p.119-129
Hauptverfasser: de Araújo, Raimundo Fernandes, de Araújo, Aurigena Antunes, Pessoa, Jonas Bispo, Freire Neto, Franscisco Paulo, da Silva, Gisele Ribeiro, Leitão Oliveira, Ana Luiza C.S., de Carvalho, Thaís Gomes, Silva, Heloiza F.O., Eugênio, Mateus, Sant’Anna, Celso, Gasparotto, Luiz H.S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Gold nanoparticles (GNPs) are regarded as potential platforms for drug delivery. However, their interaction with live organisms must be understood prior to their utilization as drug carriers. The present study reports the anti-inflammatory, analgesic and anti-tumor effects of GNPs. The biodistribution of GNPs and their effect on various tissues have also been studied. GNPs were synthesized through an environmentally friendly route and characterized with TEM and UV–vis. After HT-29 cells had been exposed to GNPs, apoptosis was assessed with Annexin V and propidium iodide staining and caspase-3 activity determined with a confocal laser scanning microscope. GNPs were administrated to male and female Swiss mice for posterior assessment of their anti-inflammatory and analgesic properties. The biodistribution of GNPs and their impact on tissues were studied with UV–vis and histopathological analysis, respectively. Cell apoptosis was observed in a dose-dependent manner for GNPs concentrations ranging from 40μg/mL to 80μg/mL (p
ISSN:1734-1140
2299-5684
DOI:10.1016/j.pharep.2016.09.017